Study shows benefit of shunt in cirrhosis

10/18/2013 | Healio (free registration)

In a study presented at the American College of Gastroenterology meeting, placement of a transjugular portosystemic shunt led to complete portal vein recanalization among 68% of cirrhotic participants with portal vein thrombosis and significant improvement among another 20%, as measured with Doppler vascular ultrasound. "This study has brought up new ideas in the field of PVT treatment," said researcher Modaresi Esfeh.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX